Therapeutic applications of mesenchymal stem cells: current outlook

Area of Science:

• Regenerative Medicine
• Cell Biology
• Immunology

Background:

• Cell-based therapies, particularly those using mesenchymal stem cells (MSCs), are rapidly advancing in clinical applications.
• MSCs, initially identified as bone marrow progenitors, exhibit potent tissue repair via secreted factors.
• These factors mediate angiogenic, trophic, anti-inflammatory, and immunomodulatory effects, making MSCs candidates for ischemic, inflammatory, and immunological disorders.

Purpose of the Study:

• To explore the largely uncharacterized heterogeneity within mesenchymal stem cell (MSC) populations.
• To understand how this heterogeneity impacts MSC biological activity and therapeutic potency.
• To address the variability observed in experimental and clinical trial outcomes for MSC-based therapies.

Main Methods:

• Review of existing literature on MSC biology and clinical trial data.
• Discussion of how population heterogeneity, sampling bias, and ex vivo expansion affect MSC function.
• Exploration of strategies to enhance reproducibility and efficacy of MSC therapies.

Main Results:

• MSC populations are heterogeneous, leading to varied biological activities and therapeutic outcomes.
• Disparate results in animal models and human clinical trials may be partly explained by this heterogeneity.
• Current knowledge gaps hinder prediction and control of MSC therapeutic potential.

Conclusions:

• Addressing mesenchymal stem cell (MSC) population heterogeneity is crucial for advancing cell-based therapies.
• Strategies to standardize MSC populations and manufacturing are needed for reliable clinical outcomes.
• Further research into MSC heterogeneity will improve the predictability and efficacy of regenerative medicine.